mmp 1 Search Results


91
Danaher Inc mmp
Mmp, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mmp/product/Danaher Inc
Average 91 stars, based on 1 article reviews
mmp - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

88
Thermo Fisher snp mmp1 c 34384693 10
Minor allele frequencies (MAF) and Hardy-Weinberg equilibrium probabilities for the investigated variants (state variants) in the control and anterior cruciate ligament rupture groups investigated in the recruited Polish cohort.
Snp Mmp1 C 34384693 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snp mmp1 c 34384693 10/product/Thermo Fisher
Average 88 stars, based on 1 article reviews
snp mmp1 c 34384693 10 - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier

94
Boster Bio matrix metalloproteinase 1
Minor allele frequencies (MAF) and Hardy-Weinberg equilibrium probabilities for the investigated variants (state variants) in the control and anterior cruciate ligament rupture groups investigated in the recruited Polish cohort.
Matrix Metalloproteinase 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matrix metalloproteinase 1/product/Boster Bio
Average 94 stars, based on 1 article reviews
matrix metalloproteinase 1 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
R&D Systems mmp 1 duoset
CSE-induced CCN1 augments matrix metalloproteinase <t>(MMP)-1</t> secretion. A: effects of CCN1 knockdown on MMP1. Beas2B cells were treated with control or CCN1 siRNA, followed with 10% CSE. MMP1 levels in supernatants were determined using ELISA 4 h later. B: the soluble factor and extracellular vehicles (EVs) were isolated from CSE-stimulated Beas2B cells. Beas2B cells were treated with control or CCN1 siRNA. The Beas2B cells were stimulated by the soluble factor (10 μg) and EV (10 μg). MMP1 was then determined using ELISA. C: Beas2B cells were treated with recombinant CCN1 (1 μg/ml), plasmin (0.1 μg/ml), and CCN1 + plasmin. After 8 h, MMP1 was determined using ELISA. CCN1 and plasmin were preincubated 1 h at 37°C before adding to the cells. D: Beas2B cells were pretreated for 1 h with TLCK before CSE, and MMP1 was determined using ELISA 8 h later. E: level of MMP1 after treatment of NH2-terminal or COOH-terminal CCN1 fragments (each 1 μg) in Beas2B cells. Supernatant (Sup) was taken after 24 h and measured MMP1. F: cell survival after treatment of NH2-terminal or COOH-terminal CCN1 fragments for 48 h in Beas2B cells. Cell survival was measured by CellTiter-Glo Luminescent cell viability assay. *P < 0.05 compared with control for A and B, sham for C and F, and CSE for D and E. **P < 0.05 compared with CCN1 and plasmin for C and NH2-terminal for E. Each panel represents at least 3 repeats with similar results.
Mmp 1 Duoset, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mmp 1 duoset/product/R&D Systems
Average 94 stars, based on 1 article reviews
mmp 1 duoset - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

96
Proteintech mmp1
CSE-induced CCN1 augments matrix metalloproteinase <t>(MMP)-1</t> secretion. A: effects of CCN1 knockdown on MMP1. Beas2B cells were treated with control or CCN1 siRNA, followed with 10% CSE. MMP1 levels in supernatants were determined using ELISA 4 h later. B: the soluble factor and extracellular vehicles (EVs) were isolated from CSE-stimulated Beas2B cells. Beas2B cells were treated with control or CCN1 siRNA. The Beas2B cells were stimulated by the soluble factor (10 μg) and EV (10 μg). MMP1 was then determined using ELISA. C: Beas2B cells were treated with recombinant CCN1 (1 μg/ml), plasmin (0.1 μg/ml), and CCN1 + plasmin. After 8 h, MMP1 was determined using ELISA. CCN1 and plasmin were preincubated 1 h at 37°C before adding to the cells. D: Beas2B cells were pretreated for 1 h with TLCK before CSE, and MMP1 was determined using ELISA 8 h later. E: level of MMP1 after treatment of NH2-terminal or COOH-terminal CCN1 fragments (each 1 μg) in Beas2B cells. Supernatant (Sup) was taken after 24 h and measured MMP1. F: cell survival after treatment of NH2-terminal or COOH-terminal CCN1 fragments for 48 h in Beas2B cells. Cell survival was measured by CellTiter-Glo Luminescent cell viability assay. *P < 0.05 compared with control for A and B, sham for C and F, and CSE for D and E. **P < 0.05 compared with CCN1 and plasmin for C and NH2-terminal for E. Each panel represents at least 3 repeats with similar results.
Mmp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mmp1/product/Proteintech
Average 96 stars, based on 1 article reviews
mmp1 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

93
Cusabio elisa calorimetric assay kits
CSE-induced CCN1 augments matrix metalloproteinase <t>(MMP)-1</t> secretion. A: effects of CCN1 knockdown on MMP1. Beas2B cells were treated with control or CCN1 siRNA, followed with 10% CSE. MMP1 levels in supernatants were determined using ELISA 4 h later. B: the soluble factor and extracellular vehicles (EVs) were isolated from CSE-stimulated Beas2B cells. Beas2B cells were treated with control or CCN1 siRNA. The Beas2B cells were stimulated by the soluble factor (10 μg) and EV (10 μg). MMP1 was then determined using ELISA. C: Beas2B cells were treated with recombinant CCN1 (1 μg/ml), plasmin (0.1 μg/ml), and CCN1 + plasmin. After 8 h, MMP1 was determined using ELISA. CCN1 and plasmin were preincubated 1 h at 37°C before adding to the cells. D: Beas2B cells were pretreated for 1 h with TLCK before CSE, and MMP1 was determined using ELISA 8 h later. E: level of MMP1 after treatment of NH2-terminal or COOH-terminal CCN1 fragments (each 1 μg) in Beas2B cells. Supernatant (Sup) was taken after 24 h and measured MMP1. F: cell survival after treatment of NH2-terminal or COOH-terminal CCN1 fragments for 48 h in Beas2B cells. Cell survival was measured by CellTiter-Glo Luminescent cell viability assay. *P < 0.05 compared with control for A and B, sham for C and F, and CSE for D and E. **P < 0.05 compared with CCN1 and plasmin for C and NH2-terminal for E. Each panel represents at least 3 repeats with similar results.
Elisa Calorimetric Assay Kits, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa calorimetric assay kits/product/Cusabio
Average 93 stars, based on 1 article reviews
elisa calorimetric assay kits - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Cusabio mmp 1
CSE-induced CCN1 augments matrix metalloproteinase <t>(MMP)-1</t> secretion. A: effects of CCN1 knockdown on MMP1. Beas2B cells were treated with control or CCN1 siRNA, followed with 10% CSE. MMP1 levels in supernatants were determined using ELISA 4 h later. B: the soluble factor and extracellular vehicles (EVs) were isolated from CSE-stimulated Beas2B cells. Beas2B cells were treated with control or CCN1 siRNA. The Beas2B cells were stimulated by the soluble factor (10 μg) and EV (10 μg). MMP1 was then determined using ELISA. C: Beas2B cells were treated with recombinant CCN1 (1 μg/ml), plasmin (0.1 μg/ml), and CCN1 + plasmin. After 8 h, MMP1 was determined using ELISA. CCN1 and plasmin were preincubated 1 h at 37°C before adding to the cells. D: Beas2B cells were pretreated for 1 h with TLCK before CSE, and MMP1 was determined using ELISA 8 h later. E: level of MMP1 after treatment of NH2-terminal or COOH-terminal CCN1 fragments (each 1 μg) in Beas2B cells. Supernatant (Sup) was taken after 24 h and measured MMP1. F: cell survival after treatment of NH2-terminal or COOH-terminal CCN1 fragments for 48 h in Beas2B cells. Cell survival was measured by CellTiter-Glo Luminescent cell viability assay. *P < 0.05 compared with control for A and B, sham for C and F, and CSE for D and E. **P < 0.05 compared with CCN1 and plasmin for C and NH2-terminal for E. Each panel represents at least 3 repeats with similar results.
Mmp 1, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mmp 1/product/Cusabio
Average 93 stars, based on 1 article reviews
mmp 1 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

86
R&D Systems detection antibody
CSE-induced CCN1 augments matrix metalloproteinase <t>(MMP)-1</t> secretion. A: effects of CCN1 knockdown on MMP1. Beas2B cells were treated with control or CCN1 siRNA, followed with 10% CSE. MMP1 levels in supernatants were determined using ELISA 4 h later. B: the soluble factor and extracellular vehicles (EVs) were isolated from CSE-stimulated Beas2B cells. Beas2B cells were treated with control or CCN1 siRNA. The Beas2B cells were stimulated by the soluble factor (10 μg) and EV (10 μg). MMP1 was then determined using ELISA. C: Beas2B cells were treated with recombinant CCN1 (1 μg/ml), plasmin (0.1 μg/ml), and CCN1 + plasmin. After 8 h, MMP1 was determined using ELISA. CCN1 and plasmin were preincubated 1 h at 37°C before adding to the cells. D: Beas2B cells were pretreated for 1 h with TLCK before CSE, and MMP1 was determined using ELISA 8 h later. E: level of MMP1 after treatment of NH2-terminal or COOH-terminal CCN1 fragments (each 1 μg) in Beas2B cells. Supernatant (Sup) was taken after 24 h and measured MMP1. F: cell survival after treatment of NH2-terminal or COOH-terminal CCN1 fragments for 48 h in Beas2B cells. Cell survival was measured by CellTiter-Glo Luminescent cell viability assay. *P < 0.05 compared with control for A and B, sham for C and F, and CSE for D and E. **P < 0.05 compared with CCN1 and plasmin for C and NH2-terminal for E. Each panel represents at least 3 repeats with similar results.
Detection Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/detection antibody/product/R&D Systems
Average 86 stars, based on 1 article reviews
detection antibody - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

99
Thermo Fisher gene exp mmp1 hs00899658 m1
Variations in the expression levels of tumor necrosis factor ( TNF) –α expression between the negative control, 1 μM Dexamethasone treatment and 0.05% H.ECM TM liposome groups compared to the LPS-treated RAW 264.7 cells ( A ) Expression levels of COL1A1 and <t>MMP1</t> genes. The expression levels of COL1A1 ( B ) and MMP1 ( C ), representing the expression of wrinkle-related factors, improved with 0.05% H.ECM TM liposome treatment compared to the negative control group of HDF cells ( B ). The 10 ng/mL recombinant EFG treatment was used as a positive control. * p < 0.05, ** p < 0.01, *** p < 0.005.
Gene Exp Mmp1 Hs00899658 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp mmp1 hs00899658 m1/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
gene exp mmp1 hs00899658 m1 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
Thermo Fisher gene exp mmp1 hs00233958 m1
Variations in the expression levels of tumor necrosis factor ( TNF) –α expression between the negative control, 1 μM Dexamethasone treatment and 0.05% H.ECM TM liposome groups compared to the LPS-treated RAW 264.7 cells ( A ) Expression levels of COL1A1 and <t>MMP1</t> genes. The expression levels of COL1A1 ( B ) and MMP1 ( C ), representing the expression of wrinkle-related factors, improved with 0.05% H.ECM TM liposome treatment compared to the negative control group of HDF cells ( B ). The 10 ng/mL recombinant EFG treatment was used as a positive control. * p < 0.05, ** p < 0.01, *** p < 0.005.
Gene Exp Mmp1 Hs00233958 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp mmp1 hs00233958 m1/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
gene exp mmp1 hs00233958 m1 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

88
Cusabio canine mmp 1
Variations in the expression levels of tumor necrosis factor ( TNF) –α expression between the negative control, 1 μM Dexamethasone treatment and 0.05% H.ECM TM liposome groups compared to the LPS-treated RAW 264.7 cells ( A ) Expression levels of COL1A1 and <t>MMP1</t> genes. The expression levels of COL1A1 ( B ) and MMP1 ( C ), representing the expression of wrinkle-related factors, improved with 0.05% H.ECM TM liposome treatment compared to the negative control group of HDF cells ( B ). The 10 ng/mL recombinant EFG treatment was used as a positive control. * p < 0.05, ** p < 0.01, *** p < 0.005.
Canine Mmp 1, supplied by Cusabio, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/canine mmp 1/product/Cusabio
Average 88 stars, based on 1 article reviews
canine mmp 1 - by Bioz Stars, 2026-02
88/100 stars
  Buy from Supplier

Image Search Results


Minor allele frequencies (MAF) and Hardy-Weinberg equilibrium probabilities for the investigated variants (state variants) in the control and anterior cruciate ligament rupture groups investigated in the recruited Polish cohort.

Journal: Genes

Article Title: Matrix Metalloproteinase Genes ( MMP1, MMP10, MMP12 ) on Chromosome 11q22 and the Risk of Non-Contact Anterior Cruciate Ligament Ruptures

doi: 10.3390/genes11070766

Figure Lengend Snippet: Minor allele frequencies (MAF) and Hardy-Weinberg equilibrium probabilities for the investigated variants (state variants) in the control and anterior cruciate ligament rupture groups investigated in the recruited Polish cohort.

Article Snippet: All samples were genotyped in duplicate, using C__34384693_10 (for the MMP1 rs1799750, -/G), C____632734_20 (for the MMP10 rs486055, C/T) and C__15880589_10 (for the MMP12 rs2276109, T/C) TaqMan ® Pre-Designed SNP Genotyping Assays (Applied Biosystems) on a StepOne Real-Time Polymerase Chain Reaction (RT-PCR) instrument (Applied Biosystems, Waltham, MA, USA) following the manufacturer’s recommendations.

Techniques: Control

Association analysis of the  MMP1  rs1799750 -/G, MMP10 rs486055 C/T and MMP12 rs2276109 T/C polymorphisms with non-contact anterior cruciate ligament (ACL) rupture.

Journal: Genes

Article Title: Matrix Metalloproteinase Genes ( MMP1, MMP10, MMP12 ) on Chromosome 11q22 and the Risk of Non-Contact Anterior Cruciate Ligament Ruptures

doi: 10.3390/genes11070766

Figure Lengend Snippet: Association analysis of the MMP1 rs1799750 -/G, MMP10 rs486055 C/T and MMP12 rs2276109 T/C polymorphisms with non-contact anterior cruciate ligament (ACL) rupture.

Article Snippet: All samples were genotyped in duplicate, using C__34384693_10 (for the MMP1 rs1799750, -/G), C____632734_20 (for the MMP10 rs486055, C/T) and C__15880589_10 (for the MMP12 rs2276109, T/C) TaqMan ® Pre-Designed SNP Genotyping Assays (Applied Biosystems) on a StepOne Real-Time Polymerase Chain Reaction (RT-PCR) instrument (Applied Biosystems, Waltham, MA, USA) following the manufacturer’s recommendations.

Techniques:

Association analysis of the  MMP1  x MMP10 interaction with non-contact ACL rupture (codominant model).

Journal: Genes

Article Title: Matrix Metalloproteinase Genes ( MMP1, MMP10, MMP12 ) on Chromosome 11q22 and the Risk of Non-Contact Anterior Cruciate Ligament Ruptures

doi: 10.3390/genes11070766

Figure Lengend Snippet: Association analysis of the MMP1 x MMP10 interaction with non-contact ACL rupture (codominant model).

Article Snippet: All samples were genotyped in duplicate, using C__34384693_10 (for the MMP1 rs1799750, -/G), C____632734_20 (for the MMP10 rs486055, C/T) and C__15880589_10 (for the MMP12 rs2276109, T/C) TaqMan ® Pre-Designed SNP Genotyping Assays (Applied Biosystems) on a StepOne Real-Time Polymerase Chain Reaction (RT-PCR) instrument (Applied Biosystems, Waltham, MA, USA) following the manufacturer’s recommendations.

Techniques:

Association analysis of the  MMP1  x MMP12 interaction with non-contact ACL rupture (codominant model).

Journal: Genes

Article Title: Matrix Metalloproteinase Genes ( MMP1, MMP10, MMP12 ) on Chromosome 11q22 and the Risk of Non-Contact Anterior Cruciate Ligament Ruptures

doi: 10.3390/genes11070766

Figure Lengend Snippet: Association analysis of the MMP1 x MMP12 interaction with non-contact ACL rupture (codominant model).

Article Snippet: All samples were genotyped in duplicate, using C__34384693_10 (for the MMP1 rs1799750, -/G), C____632734_20 (for the MMP10 rs486055, C/T) and C__15880589_10 (for the MMP12 rs2276109, T/C) TaqMan ® Pre-Designed SNP Genotyping Assays (Applied Biosystems) on a StepOne Real-Time Polymerase Chain Reaction (RT-PCR) instrument (Applied Biosystems, Waltham, MA, USA) following the manufacturer’s recommendations.

Techniques:

Haplotype-based association of  MMP1  , MMP10 and MMP12 polymorphisms (rs1799750, rs486055, rs2276109) with non-contact ACL rupture.

Journal: Genes

Article Title: Matrix Metalloproteinase Genes ( MMP1, MMP10, MMP12 ) on Chromosome 11q22 and the Risk of Non-Contact Anterior Cruciate Ligament Ruptures

doi: 10.3390/genes11070766

Figure Lengend Snippet: Haplotype-based association of MMP1 , MMP10 and MMP12 polymorphisms (rs1799750, rs486055, rs2276109) with non-contact ACL rupture.

Article Snippet: All samples were genotyped in duplicate, using C__34384693_10 (for the MMP1 rs1799750, -/G), C____632734_20 (for the MMP10 rs486055, C/T) and C__15880589_10 (for the MMP12 rs2276109, T/C) TaqMan ® Pre-Designed SNP Genotyping Assays (Applied Biosystems) on a StepOne Real-Time Polymerase Chain Reaction (RT-PCR) instrument (Applied Biosystems, Waltham, MA, USA) following the manufacturer’s recommendations.

Techniques:

CSE-induced CCN1 augments matrix metalloproteinase (MMP)-1 secretion. A: effects of CCN1 knockdown on MMP1. Beas2B cells were treated with control or CCN1 siRNA, followed with 10% CSE. MMP1 levels in supernatants were determined using ELISA 4 h later. B: the soluble factor and extracellular vehicles (EVs) were isolated from CSE-stimulated Beas2B cells. Beas2B cells were treated with control or CCN1 siRNA. The Beas2B cells were stimulated by the soluble factor (10 μg) and EV (10 μg). MMP1 was then determined using ELISA. C: Beas2B cells were treated with recombinant CCN1 (1 μg/ml), plasmin (0.1 μg/ml), and CCN1 + plasmin. After 8 h, MMP1 was determined using ELISA. CCN1 and plasmin were preincubated 1 h at 37°C before adding to the cells. D: Beas2B cells were pretreated for 1 h with TLCK before CSE, and MMP1 was determined using ELISA 8 h later. E: level of MMP1 after treatment of NH2-terminal or COOH-terminal CCN1 fragments (each 1 μg) in Beas2B cells. Supernatant (Sup) was taken after 24 h and measured MMP1. F: cell survival after treatment of NH2-terminal or COOH-terminal CCN1 fragments for 48 h in Beas2B cells. Cell survival was measured by CellTiter-Glo Luminescent cell viability assay. *P < 0.05 compared with control for A and B, sham for C and F, and CSE for D and E. **P < 0.05 compared with CCN1 and plasmin for C and NH2-terminal for E. Each panel represents at least 3 repeats with similar results.

Journal: American Journal of Physiology - Lung Cellular and Molecular Physiology

Article Title: CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke

doi: 10.1152/ajplung.00102.2014

Figure Lengend Snippet: CSE-induced CCN1 augments matrix metalloproteinase (MMP)-1 secretion. A: effects of CCN1 knockdown on MMP1. Beas2B cells were treated with control or CCN1 siRNA, followed with 10% CSE. MMP1 levels in supernatants were determined using ELISA 4 h later. B: the soluble factor and extracellular vehicles (EVs) were isolated from CSE-stimulated Beas2B cells. Beas2B cells were treated with control or CCN1 siRNA. The Beas2B cells were stimulated by the soluble factor (10 μg) and EV (10 μg). MMP1 was then determined using ELISA. C: Beas2B cells were treated with recombinant CCN1 (1 μg/ml), plasmin (0.1 μg/ml), and CCN1 + plasmin. After 8 h, MMP1 was determined using ELISA. CCN1 and plasmin were preincubated 1 h at 37°C before adding to the cells. D: Beas2B cells were pretreated for 1 h with TLCK before CSE, and MMP1 was determined using ELISA 8 h later. E: level of MMP1 after treatment of NH2-terminal or COOH-terminal CCN1 fragments (each 1 μg) in Beas2B cells. Supernatant (Sup) was taken after 24 h and measured MMP1. F: cell survival after treatment of NH2-terminal or COOH-terminal CCN1 fragments for 48 h in Beas2B cells. Cell survival was measured by CellTiter-Glo Luminescent cell viability assay. *P < 0.05 compared with control for A and B, sham for C and F, and CSE for D and E. **P < 0.05 compared with CCN1 and plasmin for C and NH2-terminal for E. Each panel represents at least 3 repeats with similar results.

Article Snippet: The human IL-8 ELISA kit was purchased from Thermo (Rockford, IL), and human VEGF and MMP-1 duoset was from R&D Systems and followed the manufacturer's instructions. .

Techniques: Enzyme-linked Immunosorbent Assay, Isolation, Recombinant, Cell Viability Assay

Variations in the expression levels of tumor necrosis factor ( TNF) –α expression between the negative control, 1 μM Dexamethasone treatment and 0.05% H.ECM TM liposome groups compared to the LPS-treated RAW 264.7 cells ( A ) Expression levels of COL1A1 and MMP1 genes. The expression levels of COL1A1 ( B ) and MMP1 ( C ), representing the expression of wrinkle-related factors, improved with 0.05% H.ECM TM liposome treatment compared to the negative control group of HDF cells ( B ). The 10 ng/mL recombinant EFG treatment was used as a positive control. * p < 0.05, ** p < 0.01, *** p < 0.005.

Journal: International Journal of Molecular Sciences

Article Title: Proteoglycan Combined with Hyaluronic Acid and Hydrolyzed Collagen Restores the Skin Barrier in Mild Atopic Dermatitis and Dry, Eczema-Prone Skin: A Pilot Study

doi: 10.3390/ijms221910189

Figure Lengend Snippet: Variations in the expression levels of tumor necrosis factor ( TNF) –α expression between the negative control, 1 μM Dexamethasone treatment and 0.05% H.ECM TM liposome groups compared to the LPS-treated RAW 264.7 cells ( A ) Expression levels of COL1A1 and MMP1 genes. The expression levels of COL1A1 ( B ) and MMP1 ( C ), representing the expression of wrinkle-related factors, improved with 0.05% H.ECM TM liposome treatment compared to the negative control group of HDF cells ( B ). The 10 ng/mL recombinant EFG treatment was used as a positive control. * p < 0.05, ** p < 0.01, *** p < 0.005.

Article Snippet: The synthesized cDNA, Taqman Gene Expression Master Mix (Applied Biosystems), and Taqman primer of each target ( HAS3 ; Hs00193436_m1, AQP3 ; Hs00185020_m1, COL1A1 : Hs00164004_m1, MMP1 : Hs00899658_m1; Filaggrin ; Hs00856927_g1, Loricrin ; Hs01894962_s1, Applied Biosystems) were used for the qRT-PCR experiments.

Techniques: Expressing, Negative Control, Recombinant, Positive Control

Expression levels of filaggrin , loricrin , HAS3, and AQP3 genes in untreated tissue specimen (negative control), and only UVB irradiated (UV), 0.1% (UV + 0.1%) and 0.2% (UV + 0.2%) H.ECM TM liposome treatment in UVB-irradiated tissue specimens. Expressions of genes encoding the factors related to the skin barrier function such as the filaggrin and loricrin were induced in the 0.1% and 0.2% H.ECM TM liposome treatment groups more than the UV group ( A ). The expression levels of genes COL1A1 and MMP1 encoding skin hydration factors were higher in the 0.1% and 0.2% H.ECM TM liposome treatments than the UV group ( B ). * p < 0.05, ** p < 0.01, *** p < 0.005.

Journal: International Journal of Molecular Sciences

Article Title: Proteoglycan Combined with Hyaluronic Acid and Hydrolyzed Collagen Restores the Skin Barrier in Mild Atopic Dermatitis and Dry, Eczema-Prone Skin: A Pilot Study

doi: 10.3390/ijms221910189

Figure Lengend Snippet: Expression levels of filaggrin , loricrin , HAS3, and AQP3 genes in untreated tissue specimen (negative control), and only UVB irradiated (UV), 0.1% (UV + 0.1%) and 0.2% (UV + 0.2%) H.ECM TM liposome treatment in UVB-irradiated tissue specimens. Expressions of genes encoding the factors related to the skin barrier function such as the filaggrin and loricrin were induced in the 0.1% and 0.2% H.ECM TM liposome treatment groups more than the UV group ( A ). The expression levels of genes COL1A1 and MMP1 encoding skin hydration factors were higher in the 0.1% and 0.2% H.ECM TM liposome treatments than the UV group ( B ). * p < 0.05, ** p < 0.01, *** p < 0.005.

Article Snippet: The synthesized cDNA, Taqman Gene Expression Master Mix (Applied Biosystems), and Taqman primer of each target ( HAS3 ; Hs00193436_m1, AQP3 ; Hs00185020_m1, COL1A1 : Hs00164004_m1, MMP1 : Hs00899658_m1; Filaggrin ; Hs00856927_g1, Loricrin ; Hs01894962_s1, Applied Biosystems) were used for the qRT-PCR experiments.

Techniques: Expressing, Negative Control, Irradiation